Antibody-based pharmaceuticals resource

Creative Biolabs has archived professional academic reports and the latest scientific progress of gene therapy, by making it into a podcast column. Here we will discuss the basic theories and clinic stages of genome editing methods, and Creative Biolabs' gene editing solutions for gene therapy development.

Creative Biolabs has archived professional academic reports and the latest scientific progress of gene therapy, by making it into a podcast column. Today we will discuss the gene delivery systems that are commonly used in research and the clinic, and the corresponding gene delivery system development services provided by Creative Biolabs.

Creative Biolabs has invited Dr. Archana Thakur and Dr. Luca Varani to walk us through how they utilize the power of bsAbs to 1) arm "headless CAR T cells" and serially kill tumor targets and 2) neutralize wild-type SARS-CoV-2 and its variants and suppress viral escape.

Creative Biolabs has archived professional academic reports and the latest scientific progress of oncolytic virus therapy, by making it into a podcast column.

Creative Biolabs has archived professional academic reports and the latest scientific progress of oncolytic virus therapy, by making it into a podcast column.

Creative Biolabs has archived professional academic reports and the latest scientific progress of oncolytic virotherapy, by making it into a podcast column.

Creative Biolabs has archived professional academic reports and the latest scientific progress of oncolytic virotherapy, by making it into a podcast column.

Creative Biolabs has archived professional academic reports and the latest scientific progress of oncolytic virus therapy, by making it into a podcast column.

Creative Biolabs has archived professional academic reports and the latest scientific progress of immune cell-based therapies, by making it into a podcast column. Here is a brief introduction to lentiviral vector gene delivery system and its applications in CAR-T cell construction.

Creative Biolabs has archived professional academic reports and the latest scientific progress of immune cell-based therapies, by making it into a podcast column. Today, we are going to share some basic knowledge about Chimeric Antigen Receptor or CAR technology and its applications in tumor therapy.

Here, we will introduce the virus and its pathogenic mechanism in detail. At the same time, you will learn how to obtain functional anti-virus antibodies and peptides through our technology platform.

In this episode, we will study the overview of membrane protein and membrane protein antibody.

What is de novo antibody sequencing? What are the steps of de novo antibody sequencing?  Are there any challenges in de novo antibody sequencing? How do we overcome these difficulties in antibody sequence analysis? Creative Biolabs will describe all these issues in the episode.

This episode introduces the De Novo Antibody Sequencing service provided by Creative Biolabs, which can distinguish leucine from isoleucine with 100% accuracy. This valuable breakthrough improves functional analysis and verification and cost-effectively builds a strong foundation for downstream applications.

In this episode, we will introduce the definition and background of immunogenicity and importance of immunogenicity therapeutic biologics development.

In this episode, Creative Biolabs will introduce technologies of monoclonal antibody development, including hybridoma, surface display, B cell immortalization, and transgenetic technology. You will have a whole concept of mAb development after listening to the episode.

As a new preparation technology for genetically engineered antibodies, antibody library technology has important theoretical and practical values in the cloning of human antibodies, antibody performance modification, and antibody gene research. Here, we will explore the de novo antibody library screening technologies and corresponding applications.

What is antibody humanization? How to humanize an antibody? The definition and humanization process are illustrated by Creative Biolabs in this episode.

In the episode, Creative Biolabs will detailed the mechanism of antibody diversity — gene rearrangement and antibody sequencing service. We hope this episode can help you understand the principle of complicated antibody diversity.

Here, we discussed the important features of antitumor antibodies, with a focus on how such antibodies promote immune effector mechanisms to control tumor growth. Approved and in clinical phase therapeutic antibodies are also mentioned.

Previously, we published part one of recombinant antibody overview which mainly focuses on antibody basic information and antibody production in vivo . In part two of this topic, we will give an introduction to recombinant antibody and recombinant antibody expression.

In this episode, we will give you a whole understanding of conventional antibody, recombinant antibody, and their basic information and expression.

In this episode, we will introduce different antibody expression systems, including common process of recombinant antibody expression and generalized features of antibody in various expression systems.

Recombinant antibodies are antibody fragments generated using recombinant antibody coding genes as a source and display technology, delivering high reproducibility, specificity, and scalability. This episode provides a comprehensive introduction to recombinant antibodies, including background, principle, and production process.

Yeast display is a novel technique widely used to express the proteins at the yeast surface after translation and maturation in a eukaryotic system. This episode gives a comprehensive introduction to yeast display, including yeast display system, the process of yeast display system construction, and application of yeast display.